In vitro determination of virulence factors activity associated with several Cryptococcus neoformans clinical isolates;Determinación in vitro de la actividad de los factores asociados con la virulencia de aislamientos clínicos del complejo Cryptococcus neoformans

Revista Iberoamericana de Micologia

Volumn 25, Issue 3, 2008, Pages 145-149

  Sánchez, Adriana ^a   Escandón, Patricia ^a   Castañeda, Elizabeth ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

Author keywords

Cryptococcus neoformans; In vitro; Phenotype; Virulence factors

Indexed keywords

LYSOPHOSPHOLIPASE; MONOPHENOL MONOOXYGENASE; PROTEINASE; UREASE;

ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS GATTII; CRYPTOCOCCUS NEOFORMANS; ENZYME ACTIVITY; FUNGAL MORPHOLOGY; FUNGAL STRAIN; FUNGAL VIRULENCE; FUNGUS CULTURE; FUNGUS ISOLATION; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; IN VITRO STUDY; NONHUMAN; PATHOGENICITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

CRYPTOCOCCUS GATTII; FILOBASIDIELLA NEOFORMANS;

EID: 53849147934     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-1406(08)70034-2     Document Type: Article

References (32)

1. Bovers M, Hagen F, Kuramae E, Diaz M, Spanjaard L, Dromer F, Hoogveld L, Boekhout T. Unique hybrids between the fungal pathogens Cryptococcus neoformans and Cryptococcus gattii. FEMS Yeast Res 2006; 6: 599-607.
2. Brueske C. Proteolytic activity of clinical isolates of Cryptococcus neoformans. J Clin Microbiol 1986; 23: 631-633.
3. Casadevall A, Perfect J. Cryptococcus neoformans. Washington, D.C., American Society for Microbiology Press, 1998.
4. Chang Y, Kwon-Chung J. Complementation of a capsule deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cel Biol 1994; 14: 4912-4919.
5. Chen S, Pirofski L, Casadevall A. Extracelullar proteins of Cryptococcus neoformans and host antibody responses. Infect Immun 1997; 65: 2599-2605.
6. Cox G, Mukherjee J, Cole GT, Casadevall A, Perfect J. Urease as a virulence factor in experimental cryptococosis. Infect Immun 2000; 68: 443-448.
7. Cox G, Mcdade H, Chen S, Gotfredson M, Wright L, Sorrell T, Leidich S, Casadevall A, Ghannoum M, Perfect J. Extracelullar phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol 2001; 39: 166-175.
8. De Souza C, Heitman J. Infects me, infects me not: phenotypic switching in fungal pathogen Cryptococcus neoformans. J Clin Inv 2001; 108: 1577-1578.
9. Escandón P, Sánchez A, Martínez M, Meyer W, Castañeda E. Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res 2006; 6: 625-635.
10. Franzot S, Mukherjee J, Cherniak R, Chen L, Hamdan J, Casadevall A. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 1998; 66: 89-97.
11. Franzot S, Salkin I, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37: 838-840.
12. Fries B, Goldman D, CherniaK R, Ju R, Casadevall A. Phenotypic switching in Cryptococcus neoformans results in changes in cellular morphology and glucoronoxylomannan structure. Infect Immun 1999; 67: 6076-6083.
13. Halliday C, Bul T, Krockenberger M, Malik R, Ellis D, Carter D. Presence of α and a mating types in enviromental and clinical collections of Cryptococcus neoformans var. gattii strains from Australia. J Clin Microbiol 1999; 37: 2920-2926.
14. Hicks J, Bahn Y, Heitman J. Pde1 phosphodiesterase modulates cyclic AMP levels through a protein kinase A mediated negative feedback loop in Cryptococcus neoformans. Eucaryot Cell 2005; 4: 1971-1981.
15. Huérfano S, Cepero MC, Castañeda E. Caracterización fenotípica de aislamientos ambientales de Cryptococcus neoformans. Biomédica 2003; 23: 328-340.
16. Kucsera J, Yarita K, Takeo K, Yoshida S, Gacser A, Hamari Z, Avasi Z, Kevei F. Intra-strain variability of Cryptococcus neoformans can be detected on phloxin B medium. J Basic Microbiol 2002; 42: 111-119.
17. Kwon-Chung KJ, Bennett JE. Cryptococcosis. En: Kwon-Chung KJ, Bennett JE (Eds.) Medical Mycology. Pennsylvania, USA Lea & Febiger Press; 1992: 397-446.
18. Kwon-Chung KJ, Boekhout T, Fell J, Diaz M. Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus (Basidiomycota, Hymenomycetes, Tremellomycetidae). Taxon 2002; 51: 804-806.
19. Leone R, Cabeli P, Sinicco A, Ito Kuwa S, Vidotto V. Relationship between protease production and capsule size in Cryptococcus neoformans. J Mycol Med 1999; 9: 42-44.
20. Latouche GN, Huynh M, Sorrell TC, Meyer W. PCR-restriction fragment lenght polymorphism analysis of the phospholipase B (PLB1) gene for subtyping of Cryptococcus neoformans isolates. Appl Environ Microbiol 2003; 69: 2080-2086.
21. McClelland E, Bernhardt P, Casadevall A. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect Immun 2006; 74: 1500-1504.
22. Meyer W, Castañeda A, Jackson S, Huynh M, Castañeda E and the Iberoamerican Cryptococcal Study Group. Molecular typing of Iberoamerican Cryptococcus neoformans isolates. Emerg Infect Dis 2003; 9: 189-195.
23. Pienthaweechai K, Ito-Kuwa S, Nakamura K, Aoiki K, Vidotto V, Koga-Ito CY. Phospholipase production in Cryptococcus neoformans isolates from AIDS patients in Thailand and Italy. J Mycol Med 1999; 9: 45-48.
24. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-842.
25. Price MF, Wilkinson ID, Gentry LO. Plate method detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
26. Ruma P, Browniee A, Sorrell T. A rapid method for detection of extracellular proteinase activity in Cryptococcus neoformans and a survey of 63 isolates. J Med Microbiol 2000; 49: 733-737.
27. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol 2001; 39: 155-168.
28. Vidotto V, Yumi-Koga-Ito C, Sinicco A, Di Perri G, Aoki S, Nakamura K. Extracelullar activity in Cryptococcus neoformans strain isolates from AIDS patients and from enviromental sources. Rev Iberoam Micol 2000; 17: 14-19.
29. Vidotto V, Ito-Kuwa S, Nakamura K S, Nakamura K, Auki S, Melhem M, Fukushima K, Bollo E. Extracelullar enzymatic activities in Cryptococcus neoformans strain isolates from AIDS patients in different countries. Rev Iberoam Micol 2006; 23: 216-220.
30. Williamson PR, Wakamatsu K, Ito S. Melanin biosynthesis in Cryptococcus neoformans. J Bacteriol 1998; 180: 1570-1572.
31. Xudong Z, Meter RW. Role of Iaccase in the biology and virulence of Cryptococcus neoformans. FEMS Yeast Res 2004; 5: 1-10.
32. Yan Z, Li X, Xu J. Geographic distribution of mating types alleles of Cryptococcus neoformans in four areas of the United States. J Clin Microbiol 2002; 40: 965-972.